About
Fong Ming Koh, a UCSF-trained developmental biologist with deep expertise in stem cells, epigenetics and cancer biology, pairs Asia-focused biopharma investing with hands-on Singapore ecosystem building and conference leadership.
Invests in
BiotechData & InfrastructureHealthtechMedical DevicesRobotics
Colleagues at LYFE Capital
Alan Wang
Managing Director at LYFE Capital
Alvin Koh
Investment Principal and Senior Director, APAC Business Development at LYFE Capital
David Liu
Director of Investor Relations at LYFE Capital
Derek Yuan
Partner at LYFE Capital
Frances Chovanec
Managing Director at LYFE Capital
Jack Chen
Partner at LYFE Capital
James Zhao
Founder and Partner at LYFE Capital
.avif)
Jing Xu
Principal at LYFE Capital